Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I single-ascending-dose study of P1201-07 in healthy overweight or obese adults
NL-OMON32187Phase 1Active, not recruiting
- Sponsor
- Piramal
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in obesity and Overweight comparing P1201-07 single ascending oral dose with Placebo (2 arms). Primary endpoints: Adverse events, Vital signs and 3 more. Started Feb 2008; status: active, not recruiting.
02
Drugs
P1201-07
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NL-OMON32187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32187.